Europe Pingueculum Drugs MarketBy Treatment (Artificial Tears /Topical Lubricants, Steroid Eye Drops, Non-steroidal Anti Inflammatory Drops and Others), Formulation Type (Eye Drops, Eye Ointments and Others), Mode of Purchase (Prescription, Over the Counter (OTC)), Drug Type (Branded and Generics), Population Type (Geriatric and Adults), End User (Hospitals, Specialty Clinics, Home Healthcare and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Others) - Industry Trends and Forecast to 2029.
Europe Pingueculum Drugs Market Analysis and Insights
A pingueculum is a typical conjunctival growth that is not malignant. The risk factors for the progression of pinguecula include exposure to ultraviolet light, trauma, wind, dust and sand, working outdoors for a long duration and advancing age.
The Europe pingueculum drugs market report provides details of market share, new developments and product pipeline analysis, the impact of domestic and localized market players, geographic expansions and technological innovations in the market. To understand the analysis and the market scenario, contact us for an analyst brief. Our team will help you create a revenue-impact solution to achieve your desired goal.
Data Bridge Market Research analyses that Europe pingueculum drugs market will grow at a CAGR of 5.9% during the forecast period of 2022 to 2029.
|
Report Metric |
Details |
|
Forecast Period |
2022 to 2029 |
|
Base Year |
2021 |
|
Historic Years |
2020 (Customisale to 2014-2019) |
|
Quantitative Units |
Revenue in USD Million, Pricing in USD |
|
Segments Covered |
By Treatment (Artificial Tears /Topical Lubricants, Steroid Eye Drops, Non-steroidal Anti Inflammatory Drops and Others), Formulation Type (Eye Drops, Eye Ointments and Others), Mode of Purchase (Prescription, Over the Counter (OTC)), Drug Type (Branded and Generics), Population Type (Geriatric and Adults), End User (Hospitals, Specialty Clinics, Home Healthcare and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Others) |
|
Countries Covered |
Russia, Spain, Turkey, Germany, Italy, United Kingdom, France, Hungary, Austria, Switzerland, Netherlands, Poland, Ireland, Norway, Lithuania and Rest of Europe |
|
Market Players Covered |
AbbVie Inc., Akorn Operating Company LLC, Alcon Inc., Amneal Pharmaceuticals LLC, Bausch & Lomb Incorporated, Bayer AG, Johnson & Johnson Consumer Inc., Novartis AG, OASIS Medical, Inc., SAGER PHARMA, Santen Pharmaceutical Co., Johnson & Johnson Vision Care, Inc., Similasan Corporation, Sylentis, Laboratoires Théa, Wellona Pharma, and Zydus Group among others |
Market Definition
A pingueculum is a typical conjunctival growth that is not malignant. This is the transparent, delicate tissue that encircles the eye's white region (sclera). Pinguecula word is derived from the Latin word pinguis, which means "fat" or "grease." The growth occurs in the part of the conjunctiva that is exposed when the eye is open. The risk factors for the progression of pinguecula include exposure to ultraviolet light, trauma, wind, dust and sand, working outdoors for a long duration and advancing age. Individuals having a history of elevated UV exposure and those living closer to the equator have a higher incidence (outdoor work). According to certain research, males have a somewhat higher incidence than females, which could simply be due to a higher rate of UV exposure. It appears as a tiny, yellowish bump on the conjunctiva close to the cornea. It may emerge on either side of the cornea.
Europe Pingueculum Drugs Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below
- Rising prevalence of pinguecula disorders and ocular pains
In 2020, according to the published article "Prevalence and associated factors of pinguecula in Western Turkey" by ULAKBİM Journal Systems, the study included 1443 individuals over the age of 20 years of Western Turkey, where it was found that 52.5% of people had pinguecula and out of that 52.5%, the prevalence of pinguecula was higher in males (58.4%), as compared to females (46.8%).
The prevalence of pinguecula disease keeps showing a surge in growth as several environmental and external factors worldwide. Chemical burns and flash burns cause significant and severe ocular pain due to irritations over the eye surface. Thus, the rising prevalence of pinguecula disorder and ocular pain is expected to drive the Europe pingueculum drugs market in the forecast period.
- Rise in chronic UV radiation exposure due to ozone defect
In 2019, according to the published journal by "the Association for Research in Vision and Ophthalmology," it was stated that early pinguecula was found to have a prevalence of 39.5% in the temporal conjunctiva and 43.9% in the nasal conjunctiva respectively. That the reported amount of time spent on outdoor activities was 19.6% and 16.1% for less than 2 hours, 44.7% and 52.2% for 4 to 6 hours, respectively and 75.0% in both fields for more than 6 hours, indicates a positive correlation between the prevalence of pinguecula and the amount of time spent on outdoor activities and UV radiation exposure.
There is a correlation between increased exposure to UV and a higher prevalence of pinguecula. This demonstrates that there is a connection between the prevalence of pinguecula and exposure to sunlight. The ozone layer defect is also leading to an increase in the exposure of UV exposure which is increasing the prevalence of pinguecula disorder. Thus, it is expected to drive The Europe pingueculum drugs market growth.
- Initiatives and plans to lessen the prevalence of eye illnesses
In 2020, The VISION 2020: The Right to Sight initiative was introduced in 1999 by the World Health Organization (WHO), Geneva, Switzerland and the International Agency for the Prevention of Blindness (IAPB), London, England. The Europe initiative VISION2020 seeks to end avoidable blindness by 2020 and focuses on the main causes of avoidable visual impairment.
According to the article by CDC (Centres for disease control and prevention), in 2022, through Vision Health Initiative (VHI) and diverse stakeholders, CDC initiated a coordinated national public health framework to prevent blindness and vision impairment.
The initiatives and plans are working as an opportunity for the market. Hence, initiatives and plans to lessen the prevalence of eye illness are expected to act as an opportunity for the growth of the Europe pingueculum drugs market.
Restraints/Challenges
- Adverse effects of steroid eye drops
Ophthalmologists or optometrists are recommended by patients with mild to severe pinguecula for a thorough examination and prompt treatment. Most often, local tropical steroids, tropical immune modulators, lubricating ointment, gel, or drops are used to treat them.
Prednisolone is the topical steroid that is most frequently used to treat ocular pain. The prednisolone acetate ophthalmic suspension has below mentioned common adverse effects:
- Eyes sting, burn, or itch for one to two minutes after using this medicine
- Vision temporarily obscured
- Increased light sensitivity
- Visual alterations
- Experiencing a foreign object in your eyes
- Allergic responses
Lack of healthcare facilities for eye treatment
As per IntechOpen 2020 report, the prevalence of blindness and ocular disorders in high-income countries is 0.3 per 1000 people, but in low-income countries, the estimation is 1.5 per 1000. This shows the unmet need for ophthalmology care in low-income countries
Another major problem in low-income countries is the lack of awareness regarding ocular pain and other disorders. Many research studies report the high requirement of low-income countries for eye health care and their unmet needs are still gaining attention among many healthcare organizations. Hence, the poor healthcare facility for eye treatments in low and middle-income countries may act as restraints for the growth of the Europe pingueculum drugs market.
Post-COVID-19 Impact on the Europe Pingueculum Drugs Market
COVID-19 has negatively affected the market. Lockdowns and isolation during the pandemic complicate disease management and medication adherence. The lack of access to healthcare facilities for routine treatment and medication administration will further impact the market.
Recent Development
- In May 2022, Alcon announced the acquisition of EYSUVIS (loteprednol etabonate suspension) pharmaceutical eye drop from Kala Pharmaceuticals, Inc. The acquisition will complement the company's Systane family of eye drops which includes preservative free formulations among others
- In September 2022, Johnson & Johnson Vision Care, Inc. announced the launch of its new innovation of Acuvue Oasys Max–day contact lenses and its multifocal contact lenses for presbyopia. Additionally, these new contact lenses are with the new technology to meet the digitally intense lifestyle
Europe Pingueculum Drugs Market Scope
The Europe pingueculum drugs market is categorized into seven notable segments based on drug type, treatment, formulation, mode of purchase, population type, end user and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Treatment
- Artificial Tears/Topical Lubricants
- Steroid Eye Drops
- Non-steroidal Eye Drops
- Others
Based on treatment, Europe pingueculum drugs market is segmented into artificial tears/topical lubricants, steroid eye drops, non-steroidal eye drops, and others.
Formulation Type
- Eye Drops
- Eye Ointments
- Others
Based on formulation, Europe pingueculum drugs market is segmented into eye drops, eye ointments, and others.
Mode of Purchase
- Prescription
- Over the Counter (OTC)
Based on mode of purchase, Europe pingueculum drugs market is segmented into prescription and over the counter (OTC).
Drug Type
- Branded
- Generics
Based on population type, Europe pingueculum drugs market is segmented into branded and generics.
Population Type
- Geriatric
- Adults
Based on population type, Europe pingueculum drugs market is segmented into geriatric and adults.
End User
- Hospitals
- Specialty Clinics
- Home Healthcare
- Others
Based on end user, Europe pingueculum drugs market is segmented into hospitals, specialty clinics, home healthcare, and others.
Distribution Channel
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
- Others
Based on the distribution channel, Europe pingueculum drugs market is segmented into retail pharmacies, hospital pharmacies, online pharmacies, and others.
Pingueculum Drug Market Regional Analysis/Insights
The Europe pingueculum drugs market is analyzed and market size insights and trends are provided by country, drug type, treatment, formulation, mode of purchase, population type, end user and distribution channel as referenced above.
The countries covered in Europe pingueculum drugs market report are Russia, Spain, Turkey, Germany, Italy, United Kingdom, France, Hungary, Austria, Switzerland, Netherlands, Poland, Ireland, Norway, Lithuania and Rest of Europe.
Spain is expected to dominate the Europe pingueculum drugs because of initiatives and plans to lessen the prevalence of eye illness. The Europe pingueculum drugs market is expected to grow due to the increasing prevalence of pingueculum in tropical areas and the growing geriatric population.
The country section of the report also provides individual market-impacting factors and changes in regulations in the market that impact the current and future trends of the market. Data points, such as new and replacement sales, country demographics, and import-export tariffs, are some of the major pointers used to forecast the market scenario for individual countries. In addition, the presence and availability of Europe brands and their challenges faced due to high competition from local and domestic brands and the impact of sales channels are considered while providing forecast analysis of the country data.
Competitive Landscape and Pingueculum drugs market Share Analysis
Europe pingueculum drugs market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, European presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus related to Europe pingueculum drugs market.
Some of the major players operating in Europe pingueculum drugs market are AbbVie Inc., Akorn Operating Company LLC, Alcon Inc., Amneal Pharmaceuticals LLC, Bausch & Lomb Incorporated, Bayer AG, Johnson & Johnson Consumer Inc., Novartis AG, OASIS Medical, Inc., SAGER PHARMA, Santen Pharmaceutical Co., Johnson & Johnson Vision Care, Inc., Similasan Corporation, Sylentis, Laboratoires Théa, Wellona Pharma, and Zydus Group among others.
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by the DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Europe Vs. Regional, and Vendor Share Analysis. Please request an analyst call in case of further inquiry.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market, and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you with data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE EUROPE PINGUECULUM DRUGS MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 EUROPE PINGUECULUM DRUGS MARKET: SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 MULTIVARIATE MODELLING
2.8 TREATMENT LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 MARKET END-USER COVERAGE GRID
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 EPIDERMIOLOGY
4.2 PESTEL ANALYSIS
4.3 PORTER’S FIVE FORCES
4.4 PIPELINE ANALYSIS FOR THE EUROPE PINGUECULUM DRUGS MARKET
4.5 INDUSTRIAL INSIGHTS:
4.6 CONCLUSION:
5 EUROPE PINGUECULUM DRUGS MARKET: REGULATIONS
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 RISING PREVALENCE OF PINGUECELA DISORDERS AND OCULAR PAINS
6.1.2 RISE IN THE CHRONIC UV RADIATION EXPOSURE DUE TO OZONE DEFECT
6.1.3 INCREASING AWARENESS AMONG PEOPLE FOR EYE-RELATED DISEASES
6.1.4 RISING OPHTHALMIC EMERGENCIES IN THE GERIATRIC PATIENT
6.2 RESTRAINTS
6.2.1 STRINGENT RULES & REGULATIONS
6.2.2 LACK OF HEALTHCARE FACILITIES FOR EYE TREATMENT
6.3 OPPORTUNITIES
6.3.1 INITIATIVES AND PLANS TO LESSEN THE PREVALENCE OF EYE ILLNESSES
6.3.2 INCREASING RESEARCH AND DEVELOPMENT ACTIVITIES
6.3.3 INCREASE IN HEALTHCARE SPENDING AND ACCESSIBLE INCOME
6.4 CHALLENGES
6.4.1 ADVERSE EFFECTS OF STEROID EYE DROPS
6.4.2 LACK OF SKILLED OPHTHALMOLOGISTS
7 EUROPE PINGUECULUM DRUGS MARKET, BY TREATMENT
7.1 OVERVIEW
7.2 ARTIFICIAL TEARS/TOPICAL LUBRICANTS
7.2.1 DEMULCENT
7.2.2 EMOLLIENTS
7.3 STEROID EYE DROPS
7.3.1 KETONE STEROIDS
7.3.1.1 PREDNISOLONE
7.3.1.2 DEXAMETHASONE
7.3.1.3 FLUROMETHOLONE
7.3.1.4 MEDRYSONE
7.3.1.5 RIMEXOLONE
7.3.1.6 OTHERS
7.3.2 ESTER STEROID (LOTERPREDNOL)
7.4 NON-STEROIDAL ANTI-INFLAMMATORY DROPS
7.5 OTHERS
8 EUROPE PINGUECULUM DRUGS MARKET, BY FORMULATION
8.1 OVERVIEW
8.2 EYE DROPS
8.2.1 EYE DROPS WITH PRESERVATIVES
8.2.2 PRESERVATIVE-FREE EYE DROPS
8.3 EYE OINTMENTS
8.3.1 WITH PRESERVATIVES
8.3.2 PRESERVATIVE-FREE
8.3.3 OTHERS
8.4 OTHERS
9 EUROPE PINGUECULUM DRUGS MARKET, MODE OF PURCHASE
9.1 OVERVIEW
9.2 PRESCRIPTION
9.3 OVER THE COUNTER (OTC)
10 EUROPE PINGUECULUM DRUGS MARKET, BY DRUGS TYPE
10.1 OVERVIEW
10.2 BRANDED
10.3 GENERICS
11 EUROPE PINGUECULUM DRUGS MARKET, BY POPULATION TYPE
11.1 OVERVIEW
11.2 GERIATRIC
11.2.1 MALE
11.2.2 FEMALE
11.3 ADULTS
11.3.1 MALE
11.3.2 FEMALE
12 EUROPE PINGUECULUM DRUGS MARKET, BY END USER
12.1 OVERVIEW
12.2 HOSPITALS
12.3 SPECIALTY CLINICS
12.4 HOME HEALTHCARE
12.5 OTHERS
13 EUROPE PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL
13.1 OVERVIEW
13.2 RETAIL PHARMACIES
13.3 HOSPITAL PHARMACIES
13.4 ONLINE PHARMACIES
13.5 OTHERS
14 EUROPE PINGUECULUM DRUGS MARKET, BY REGION
14.1 EUROPE
14.1.1 SPAIN
14.1.2 RUSSIA
14.1.3 TURKEY
14.1.4 GERMANY
14.1.5 ITALY
14.1.6 U.K.
14.1.7 FRANCE
14.1.8 HUNGARY
14.1.9 AUSTRIA
14.1.10 SWITZERLAND
14.1.11 NETHERLANDS
14.1.12 POLAND
14.1.13 IRELAND
14.1.14 NORWAY
14.1.15 LITHUANIA
14.1.16 REST OF EUROPE
15 EUROPE PINGUECULUM DRUGS MARKET: COMPANY LANDSCAPE
15.1 COMPANY SHARE ANALYSIS: EUROPE
16 SWOT ANALYSIS
17 COMPANY PROFILE
17.1 ALCON INC.
17.1.1 COMPANY SNAPSHOT
17.1.2 REVENUE ANALYSIS
17.1.3 COMPANY SHARE ANALYSIS
17.1.4 PRODUCT PORTFOLIO
17.1.5 RECENT DEVELOPMENT
17.2 ABBVIE INC.
17.2.1 COMPANY SNAPSHOT
17.2.2 REVENUE ANALYSIS
17.2.3 COMPANY SHARE ANALYSIS
17.2.4 PRODUCT PORTFOLIO
17.2.5 RECENT DEVELOPMENT
17.3 BAUSCH & LOMB INCORPORATED
17.3.1 COMPANY SNAPSHOT
17.3.2 REVENUE ANALYSIS
17.3.3 COMPANY SHARE ANALYSIS
17.3.4 PRODUCT PORTFOLIO
17.3.5 RECENT DEVELOPMENT
17.4 BAYER AG
17.4.1 COMPANY SNAPSHOT
17.4.2 REVENUE ANALYSIS
17.4.3 COMPANY SHARE ANALYSIS
17.4.4 PRODUCT PORTFOLIO
17.4.5 RECENT DEVELOPMENTS
17.5 JOHNSON & JOHNSON VISION CARE, INC.
17.5.1 COMPANY SNAPSHOT
17.5.2 REVENUE ANALYSIS
17.5.3 COMPANY SHARE ANALYSIS
17.5.4 PRODUCT PORTFOLIO
17.5.5 RECENT DEVELOPMENT
17.6 AKORN OPERATING COMPANY LLC
17.6.1 COMPANY SNAPSHOT
17.6.2 . PRODUCT PORTFOLIO
17.6.3 RECENT DEVELOPMENT
17.7 AMNEAL PHARMACEUTICALS LLC.
17.7.1 COMPANY SNAPSHOT
17.7.2 REVENUE ANALYSIS
17.7.3 PRODUCT PORTFOLIO
17.7.4 RECENT DEVELOPMENTS
17.8 EYERIS VISIONCARE PVT. LTD.
17.8.1 COMPANY SNAPSHOT
17.8.2 PRODUCT PORTFOLIO
17.8.3 RECENT DEVELOPMENTS
17.9 LABORATOIRES THÉA
17.9.1 COMPANY SNAPSHOT
17.9.2 PRODUCT PORTFOLIO
17.9.3 RECENT DEVELOPMENT
17.1 MAYA BIOTECH PRIVATE LIMITED
17.10.1 COMPANY SNAPSHOT
17.10.2 PRODUCT PORTFOLIO
17.10.3 RECENT DEVELOPMENTS
17.11 NOVARTIS AG
17.11.1 COMPANY SNAPSHOT
17.11.2 REVENUE ANALYSIS
17.11.3 PRODUCT PORTFOLIO
17.11.4 RECENT DEVELOPMENT
17.12 OASIS MEDICAL, INC.
17.12.1 COMPANY SNAPSHOT
17.12.2 PRODUCT PORTFOLIO
17.12.3 RECENT DEVELOPMENT
17.13 PRESTIGE CONSUMER HEALTHCARE, INC.
17.13.1 COMPANY SNAPSHOT
17.13.2 PRODUCT PORTFOLIO
17.13.3 RECENT DEVELOPMENT
17.14 SAGER PHARMA
17.14.1 COMPANY SNAPSHOT
17.14.2 PRODUCT PORTFOLIO
17.14.3 RECENT DEVELOPMENTS
17.15 SANTEN PHARMACEUTICAL CO., LTD.
17.15.1 COMPANY SNAPSHOT
17.15.2 REVENUE ANALYSIS
17.15.3 PRODUCT PORTFOLIO
17.15.4 RECENT DEVELOPMENTS
17.16 SIMILASAN CORPORATION
17.16.1 COMPANY SNAPSHOT
17.16.2 PRODUCT PORTFOLIO
17.16.3 RECENT DEVELOPMENTS
17.17 SPECTRA VISION CARE
17.17.1 COMPANY SNAPSHOT
17.17.2 PRODUCT PORTFOLIO
17.17.3 RECENT DEVELOPMENTS
17.18 SYLENTIS
17.18.1 COMPANY SNAPSHOT
17.18.2 PRODUCT PORTFOLIO
17.18.3 RECENT DEVELOPMENTS
17.19 WELLONA PHARMA
17.19.1 COMPANY SNAPSHOT
17.19.2 PRODUCT PORTFOLIO
17.19.3 RECENT DEVELOPMENTS
17.2 ZYDUS GROUP
17.20.1 COMPANY SNAPSHOT
17.20.2 REVENUE ANALYSIS
17.20.3 PRODUCT PORTFOLIO
17.20.4 RECENT DEVELOPMENTS
18 QUESTIONNAIRE
19 RELATED REPORTS
List of Table
TABLE 1 EUROPE PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)
TABLE 2 EUROPE ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 3 EUROPE ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 4 EUROPE STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 5 EUROPE STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 6 EUROPE KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 7 EUROPE NON-STEROIDAL ANTI-INFLAMMATORY DROPS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 8 EUROPE OTHERS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 9 EUROPE PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 10 EUROPE EYE DROPS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 11 EUROPE EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 12 EUROPE EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 13 EUROPE EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 14 EUROPE OTHERS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 15 EUROPE PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)
TABLE 16 EUROPE PRESCRIPTION IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 17 EUROPE OVER THE COUNTER (OTC) IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 18 EUROPE PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)
TABLE 19 EUROPE BRANDED IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 20 EUROPE GENERICS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 21 EUROPE PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 22 EUROPE GERIATRIC IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 23 EUROPE GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 24 EUROPE ADULTS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 25 EUROPE ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 26 EUROPE PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 27 EUROPE HOSPITALS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 28 EUROPE SPECIALTY CLINICS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 29 EUROPE HOME HEALTHCARE IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 30 EUROPE OTHERS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 31 EUROPE PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 32 EUROPE RETAIL PHARMACIES IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 33 EUROPE HOSPITAL PHARMACIES IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 34 EUROPE ONLINE PHARMACIES IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 35 EUROPE OTHERS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 36 EUROPE PINGUECULUM DRUGS MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
TABLE 37 EUROPE PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)
TABLE 38 EUROPE ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 39 EUROPE STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 40 EUROPE KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 41 EUROPE PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 42 EUROPE EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 43 EUROPE EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 44 EUROPE PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)
TABLE 45 EUROPE PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)
TABLE 46 EUROPE PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 47 EUROPE GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 48 EUROPE ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 49 EUROPE PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 50 EUROPE PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 51 SPAIN PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)
TABLE 52 SPAIN ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 53 SPAIN STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 54 SPAIN KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 55 SPAIN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 56 SPAIN EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 57 SPAIN EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 58 SPAIN PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)
TABLE 59 SPAIN PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)
TABLE 60 SPAIN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 61 SPAIN GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 62 SPAIN ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 63 SPAIN PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 64 SPAIN PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 65 RUSSIA PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)
TABLE 66 RUSSIA ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 67 RUSSIA STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 68 RUSSIA KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 69 RUSSIA PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 70 RUSSIA EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 71 RUSSIA EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 72 RUSSIA PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)
TABLE 73 RUSSIA PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)
TABLE 74 RUSSIA PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 75 RUSSIA GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 76 RUSSIA ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 77 RUSSIA PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 78 RUSSIA PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 79 TURKEY PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)
TABLE 80 TURKEY ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 81 TURKEY STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 82 TURKEY KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 83 TURKEY PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 84 TURKEY EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 85 TURKEY EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 86 TURKEY PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)
TABLE 87 TURKEY PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)
TABLE 88 TURKEY PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 89 TURKEY GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 90 TURKEY ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 91 TURKEY PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 92 TURKEY PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 93 GERMANY PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)
TABLE 94 GERMANY ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 95 GERMANY STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 96 GERMANY KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 97 GERMANY PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 98 GERMANY EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 99 GERMANY EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 100 GERMANY PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)
TABLE 101 GERMANY PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)
TABLE 102 GERMANY PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 103 GERMANY GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 104 GERMANY ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 105 GERMANY PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 106 GERMANY PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 107 ITALY PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)
TABLE 108 ITALY ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 109 ITALY STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 110 ITALY KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 111 ITALY PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 112 ITALY EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 113 ITALY EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 114 ITALY PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)
TABLE 115 ITALY PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)
TABLE 116 ITALY PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 117 ITALY GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 118 ITALY ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 119 ITALY PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 120 ITALY PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 121 U.K. PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)
TABLE 122 U.K. ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 123 U.K. STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 124 U.K. KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 125 U.K. PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 126 U.K. EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 127 U.K. EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 128 U.K. PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)
TABLE 129 U.K. PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)
TABLE 130 U.K. PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 131 U.K. GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 132 U.K. ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 133 U.K. PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 134 U.K. PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 135 FRANCE PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)
TABLE 136 FRANCE ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 137 FRANCE STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 138 FRANCE KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 139 FRANCE PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 140 FRANCE EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 141 FRANCE EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 142 FRANCE PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)
TABLE 143 FRANCE PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)
TABLE 144 FRANCE PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 145 FRANCE GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 146 FRANCE ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 147 FRANCE PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 148 FRANCE PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 149 HUNGARY PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)
TABLE 150 HUNGARY ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 151 HUNGARY STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 152 HUNGARY KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 153 HUNGARY PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 154 HUNGARY EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 155 HUNGARY EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 156 HUNGARY PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)
TABLE 157 HUNGARY PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)
TABLE 158 HUNGARY PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 159 HUNGARY GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 160 HUNGARY ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 161 HUNGARY PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 162 HUNGARY PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 163 AUSTRIA PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)
TABLE 164 AUSTRIA ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 165 AUSTRIA STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 166 AUSTRIA KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 167 AUSTRIA PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 168 AUSTRIA EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 169 AUSTRIA EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 170 AUSTRIA PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)
TABLE 171 AUSTRIA PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)
TABLE 172 AUSTRIA PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 173 AUSTRIA GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 174 AUSTRIA ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 175 AUSTRIA PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 176 AUSTRIA PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 177 SWITZERLAND PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)
TABLE 178 SWITZERLAND ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 179 SWITZERLAND STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 180 SWITZERLAND KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 181 SWITZERLAND PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 182 SWITZERLAND EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 183 SWITZERLAND EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 184 SWITZERLAND PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)
TABLE 185 SWITZERLAND PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)
TABLE 186 SWITZERLAND PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 187 SWITZERLAND GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 188 SWITZERLAND ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 189 SWITZERLAND PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 190 SWITZERLAND PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 191 NETHERLANDS PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)
TABLE 192 NETHERLANDS ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 193 NETHERLANDS STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 194 NETHERLANDS KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 195 NETHERLANDS PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 196 NETHERLANDS EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 197 NETHERLANDS EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 198 NETHERLANDS PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)
TABLE 199 NETHERLANDS PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)
TABLE 200 NETHERLANDS PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 201 NETHERLANDS GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 202 NETHERLANDS ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 203 NETHERLANDS PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 204 NETHERLANDS PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 205 POLAND PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)
TABLE 206 POLAND ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 207 POLAND STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 208 POLAND KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 209 POLAND PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 210 POLAND EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 211 POLAND EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 212 POLAND PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)
TABLE 213 POLAND PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)
TABLE 214 POLAND PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 215 POLAND GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 216 POLAND ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 217 POLAND PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 218 POLAND PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 219 IRELAND PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)
TABLE 220 IRELAND ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 221 IRELAND STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 222 IRELAND KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 223 IRELAND PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 224 IRELAND EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 225 IRELAND EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 226 IRELAND PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)
TABLE 227 IRELAND PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)
TABLE 228 IRELAND PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 229 IRELAND GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 230 IRELAND ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 231 IRELAND PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 232 IRELAND PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 233 NORWAY PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)
TABLE 234 NORWAY ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 235 NORWAY STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 236 NORWAY KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 237 NORWAY PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 238 NORWAY EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 239 NORWAY EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 240 NORWAY PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)
TABLE 241 NORWAY PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)
TABLE 242 NORWAY PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 243 NORWAY GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 244 NORWAY ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 245 NORWAY PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 246 NORWAY PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 247 LITHUANIA PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)
TABLE 248 LITHUANIA ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 249 LITHUANIA STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 250 LITHUANIA KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 251 LITHUANIA PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 252 LITHUANIA EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 253 LITHUANIA EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 254 LITHUANIA PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)
TABLE 255 LITHUANIA PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)
TABLE 256 LITHUANIA PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 257 LITHUANIA GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 258 LITHUANIA ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 259 LITHUANIA PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 260 LITHUANIA PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 261 REST OF EUROPE PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)
List of Figure
FIGURE 1 EUROPE PINGUECULUM DRUGS MARKET: SEGMENTATION
FIGURE 2 EUROPE PINGUECULUM DRUGS MARKET: DATA TRIANGULATION
FIGURE 3 EUROPE PINGUECULUM DRUGS MARKET: DROC ANALYSIS
FIGURE 4 EUROPE PINGUECULUM DRUGS MARKET: EUROPE VS REGIONAL MARKET ANALYSIS
FIGURE 5 EUROPE PINGUECULUM DRUGS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE PINGUECULUM DRUGS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 EUROPE PINGUECULUM DRUGS MARKET: DBMR POSITION GRID
FIGURE 8 EUROPE PINGUECULUM DRUGS MARKET: VENDOR SHARE ANALYSIS
FIGURE 9 EUROPE PINGUECULUM DRUGS MARKET: END USER COVERAGE GRID
FIGURE 10 EUROPE PINGUECULUM DRUGS MARKET: SEGMENTATION
FIGURE 11 INCREASING PREVALENCE OF OPHTHALMIC DISORDERS AND THE RISE IN THE GERIATRIC POPULATION ARE EXPECTED TO DRIVE THE EUROPE PINGUECULUM DRUGS MARKET GROWTH FROM 2022 TO 2029
FIGURE 12 ARTIFICIAL TEARS/TOPICAL LUBRICANTS SEGMENT IS EXPECTED TO HAVE THE LARGEST SHARE OF THE EUROPE PINGUECULUM DRUGS MARKET FROM 2022 & 2029
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE EUROPE PINGUECULUM DRUGS MARKET
FIGURE 14 EUROPE PINGUECULUM DRUGS MARKET: BY TREATMENT, 2021
FIGURE 15 EUROPE PINGUECULUM DRUGS MARKET: BY TREATMENT, 2022-2029 (USD MILLION)
FIGURE 16 EUROPE PINGUECULUM DRUGS MARKET: BY TREATMENT, CAGR (2022-2029)
FIGURE 17 EUROPE PINGUECULUM DRUGS MARKET: BY TREATMENT, LIFELINE CURVE
FIGURE 18 EUROPE PINGUECULUM DRUGS MARKET: BY FORMULATION, 2021
FIGURE 19 EUROPE PINGUECULUM DRUGS MARKET: BY FORMULATION, 2022-2029 (USD MILLION)
FIGURE 20 EUROPE PINGUECULUM DRUGS MARKET: BY FORMULATION, CAGR (2022-2029)
FIGURE 21 EUROPE PINGUECULUM DRUGS MARKET: BY FORMULATION, LIFELINE CURVE
FIGURE 22 EUROPE PINGUECULUM DRUGS MARKET: BY MODE OF PURCHASE, 2021
FIGURE 23 EUROPE PINGUECULUM DRUGS MARKET: BY MODE OF PURCHASE, 2022-2029 (USD MILLION)
FIGURE 24 EUROPE PINGUECULUM DRUGS MARKET: BY MODE OF PURCHASE, CAGR (2022-2029)
FIGURE 25 EUROPE PINGUECULUM DRUGS MARKET: BY MODE OF PURCHASE, LIFELINE CURVE
FIGURE 26 EUROPE PINGUECULUM DRUGS MARKET: BY DRUGS TYPE, 2021
FIGURE 27 EUROPE PINGUECULUM DRUGS MARKET: BY DRUGS TYPE, 2022-2029 (USD MILLION)
FIGURE 28 EUROPE PINGUECULUM DRUGS MARKET: BY DRUGS TYPE, CAGR (2022-2029)
FIGURE 29 EUROPE PINGUECULUM DRUGS MARKET: BY DRUGS TYPE, LIFELINE CURVE
FIGURE 30 EUROPE PINGUECULUM DRUGS MARKET: BY POPULATION TYPE, 2021
FIGURE 31 EUROPE PINGUECULUM DRUGS MARKET: BY POPULATION TYPE, 2022-2029 (USD MILLION)
FIGURE 32 EUROPE PINGUECULUM DRUGS MARKET: BY POPULATION TYPE, CAGR (2022-2029)
FIGURE 33 EUROPE PINGUECULUM DRUGS MARKET: BY POPULATION TYPE, LIFELINE CURVE
FIGURE 34 EUROPE PINGUECULUM DRUGS MARKET: BY END USER, 2021
FIGURE 35 EUROPE PINGUECULUM DRUGS MARKET: BY END USER, 2022-2029 (USD MILLION)
FIGURE 36 EUROPE PINGUECULUM DRUGS MARKET: BY END USER, CAGR (2022-2029)
FIGURE 37 EUROPE PINGUECULUM DRUGS MARKET: BY END USER, LIFELINE CURVE
FIGURE 38 EUROPE PINGUECULUM DRUGS MARKET: BY DISTRIBUTION CHANNEL, 2021
FIGURE 39 EUROPE PINGUECULUM DRUGS MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
FIGURE 40 EUROPE PINGUECULUM DRUGS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)
FIGURE 41 EUROPE PINGUECULUM DRUGS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 42 EUROPE PINGUECULUM DRUGS MARKET: SNAPSHOT (2021)
FIGURE 43 EUROPE PINGUECULUM DRUGS MARKET: BY COUNTRY (2021)
FIGURE 44 EUROPE PINGUECULUM DRUGS MARKET: BY COUNTRY (2022 & 2029)
FIGURE 45 EUROPE PINGUECULUM DRUGS MARKET: BY COUNTRY (2021 & 2029)
FIGURE 46 EUROPE PINGUECULUM DRUGS MARKET: BY TREATMENT (2022-2029)
FIGURE 47 EUROPE PINGUECULUM DRUGS MARKET: COMPANY SHARE 2021 (%)
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
